ID
45369
Beschreibung
Principal Investigator: Arul M. Chinnaiyan, MD, PhD, University of Michigan, Ann Arbor, MI, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000567 Transcriptome sequencing of solitary fibrous tumors / hemangiopericytomas from a variety of anatomic sites revealed recurrent gene fusions between two genes, NAB2 and STAT6. All SFTs examined exhibited an in-frame fusion transcript encoding a fusion protein containing the EGR1 interaction domain of NAB2 with the transcriptional activation domain of STAT6. Functional testing of the fusion alleles confirmed the conversion of the wt NAB2 repressor into a transcriptional activator. A range of individual fusion junctions can be detected by next-generation sequencing acro the sample set, highlighting the suitability of this method in the diagnostic characterization of SFTs. This study indentified the pathognomonic alteration in solitary fibrous tumors and illuminates a pathway towards targeted therapeutics for this cancer.
Link
Stichworte
Versionen (1)
- 04.11.22 04.11.22 - Chiara Middel
Rechteinhaber
Arul M. Chinnaiyan, MD, PhD, University of Michigan, Ann Arbor, MI, USA
Hochgeladen am
4. November 2022
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
dbGaP phs000567 NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, subject source ID, and affection status of participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable associated with participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Subject ID, gender, age, anatomic site of tumor, tumor status [malignant or benign] of participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, and alias name of samples obtained from healthy participants involved in the "Phase I Clinical Trial Describing the Pharmacogenomics of Aspirin" project.
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, subject source ID, and affection status of participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Subject ID, sample ID, sample source, sample source ID, and sample use variable associated with participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Subject ID, gender, age, anatomic site of tumor, tumor status [malignant or benign] of participants with solitary fibrous tumor / hemangiopericytoma and involved in the "Identification of Recurrent NAB2-STAT6 Gene Fusions in Solitary Fibrous Tumor by Integrative Sequencing" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, and alias name of samples obtained from healthy participants involved in the "Phase I Clinical Trial Describing the Pharmacogenomics of Aspirin" project.
C1266119 (UMLS CUI [1,2])
C0018922 (UMLS CUI [1,3])
C1513749 (UMLS CUI [1,4])
C2945760 (UMLS CUI [1,5])
C0178648 (UMLS CUI [1,6])
C1417589 (UMLS CUI [1,7])
C1335877 (UMLS CUI [1,8])
C1266119 (UMLS CUI [2,1])
C3481430 (UMLS CUI [2,2])
C2700640 (UMLS CUI [2,3])
C0162768 (UMLS CUI [2,4])
C1414314 (UMLS CUI [2,5])
C1515032 (UMLS CUI [2,6])
C1417589 (UMLS CUI [2,7])
C1519594 (UMLS CUI [2,8])
C1335877 (UMLS CUI [2,9])
C0205245 (UMLS CUI [3,1])
C0039593 (UMLS CUI [3,2])
C0521091 (UMLS CUI [3,3])
C0439836 (UMLS CUI [3,4])
C1417589 (UMLS CUI [3,5])
C1336789 (UMLS CUI [3,6])
C0332286 (UMLS CUI [3,7])
C1533729 (UMLS CUI [3,8])
C0178648 (UMLS CUI [4,1])
C1511790 (UMLS CUI [4,2])
C4330825 (UMLS CUI [4,3])
C4525099 (UMLS CUI [4,4])
C0348026 (UMLS CUI [4,5])
C1880022 (UMLS CUI [4,6])
C1266119 (UMLS CUI [4,7])
C0205396 (UMLS CUI [5,1])
C2986472 (UMLS CUI [5,2])
C1515926 (UMLS CUI [5,3])
C1266119 (UMLS CUI [5,4])
C1527148 (UMLS CUI [5,5])
C2985566 (UMLS CUI [5,6])